166 related articles for article (PubMed ID: 21212673)
1. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis.
Busseuil D; Shi Y; Mecteau M; Brand G; Gillis MA; Thorin E; Asselin C; Roméo P; Leung TK; Latour JG; Des Rosiers C; Bouly M; Rhéaume E; Tardif JC
Cardiology; 2010; 117(3):234-42. PubMed ID: 21212673
[TBL] [Abstract][Full Text] [Related]
2. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
3. I(f) inhibition in cardiovascular diseases.
Thollon C; Vilaine JP
Adv Pharmacol; 2010; 59():53-92. PubMed ID: 20933199
[TBL] [Abstract][Full Text] [Related]
4. Effect of selective heart rate reduction through sinus node I
Sisakian H; Sargsyan T; Khachatryan A
Acta Cardiol; 2016 Jun; 71(3):317-22. PubMed ID: 27594127
[No Abstract] [Full Text] [Related]
5. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
Ceconi C; Cargnoni A; Francolini G; Parinello G; Ferrari R
Cardiovasc Res; 2009 Oct; 84(1):72-82. PubMed ID: 19477966
[TBL] [Abstract][Full Text] [Related]
6. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
[TBL] [Abstract][Full Text] [Related]
7. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
Perry CM
Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Borer JS; Le Heuzey JY
Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
[TBL] [Abstract][Full Text] [Related]
9. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels.
Bucchi A; Tognati A; Milanesi R; Baruscotti M; DiFrancesco D
J Physiol; 2006 Apr; 572(Pt 2):335-46. PubMed ID: 16484306
[TBL] [Abstract][Full Text] [Related]
10. Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
Becher PM; Lindner D; Miteva K; Savvatis K; Zietsch C; Schmack B; Van Linthout S; Westermann D; Schultheiss HP; Tschöpe C
Hypertension; 2012 May; 59(5):949-57. PubMed ID: 22493071
[TBL] [Abstract][Full Text] [Related]
11. Ivabradine: pharmacodynamic aspects of its clinical use.
Stieber J
Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
[TBL] [Abstract][Full Text] [Related]
12. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
Prasad UK; Gray D; Purcell H
Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
[TBL] [Abstract][Full Text] [Related]
13. The role of the funny current in pacemaker activity.
DiFrancesco D
Circ Res; 2010 Feb; 106(3):434-46. PubMed ID: 20167941
[TBL] [Abstract][Full Text] [Related]
14. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
Ferrari R; Ceconi C
Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041
[TBL] [Abstract][Full Text] [Related]
15. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.
Reil JC; Reil GH; Böhm M
Trends Cardiovasc Med; 2009 Jul; 19(5):152-7. PubMed ID: 20005474
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress.
Kröller-Schön S; Schulz E; Wenzel P; Kleschyov AL; Hortmann M; Torzewski M; Oelze M; Renné T; Daiber A; Münzel T
Basic Res Cardiol; 2011 Nov; 106(6):1147-58. PubMed ID: 21964558
[TBL] [Abstract][Full Text] [Related]
17. The heart rate-lowering agent ivabradine inhibits the pacemaker current I(f) in human atrial myocytes.
El Chemaly A; Magaud C; Patri S; Jayle C; Guinamard R; Bois P
J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1190-6. PubMed ID: 17850290
[TBL] [Abstract][Full Text] [Related]
18. Ivabradine: from molecular basis to clinical effectiveness.
Riccioni G
Adv Ther; 2010 Mar; 27(3):160-7. PubMed ID: 20419486
[TBL] [Abstract][Full Text] [Related]
19. Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.
Kim BH; Cho KI; Kim SM; Kim N; Han J; Kim JY; Kim IJ
Heart Vessels; 2013 Jul; 28(4):524-35. PubMed ID: 23142972
[TBL] [Abstract][Full Text] [Related]
20. Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle.
Leoni AL; Marionneau C; Demolombe S; Le Bouter S; Mangoni ME; Escande D; Charpentier F
Physiol Genomics; 2005 Dec; 24(1):4-12. PubMed ID: 16219869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
